Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a chest injection ease post-surgery pain better than standard care?

NCT ID NCT00210132

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 41 times

Summary

This study tested whether injecting the numbing drug ropivacaine into the chest cavity can reduce severe pain after lung cancer surgery. 90 adults having a thoracotomy for cancer received either ropivacaine or a saltwater placebo every 6 hours for 2 days. The main goal was to see if fewer patients had major pain when moving.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest

    Bordeaux, 33076, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ropivacaine

What this could lead to

If it works, this could offer a simpler, safer way to manage severe pain after lung cancer surgery.

What could go wrong

This is a small, completed phase 2 trial, so results may not apply broadly. Intrapleural analgesia has shown inconsistent effectiveness in past studies.

Conditions

The condition(s) this trial relates to.

cancer neoplasm Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.